Dr. Raphael Schneider

Dr. Schneider is a Neurologist at the BARLO MS Centre in Toronto. He is an Assistant Professor in the Department of Medicine and the Institute of Medical Science at the University of Toronto. Before joining the BARLO MS Centre in 2020, he completed a Ph.D. in Neuroscience at the University of Toronto in Dr. Janice Robertson’s laboratory and a postdoctoral fellowship in Neuroimmunology at the Université de Montréal in Dr. Nathalie Arbour’s laboratory. Dr. Schneider’s primary research focus is finding new blood and spinal fluid biomarkers for people with MS (pwMS). Since starting his faculty position in July 2020, Dr. Schneider has been actively collaborating with Dr. Jiwon Oh on biomarker discovery in people with radiologically isolated syndrome (RIS). The primary purpose of studying RIS is to identify biomarkers related to the risk of developing MS in its earliest stage. Such biomarkers would allow patients and clinicians to be proactive and take steps to prevent the accumulation of disability and ultimately optimize long-term health outcomes. The work is supported by an MS Canada Discovery Grant 2022.